Adalimumab reduces pain and fatigue in ankylosing spondylitis (AS) patients - Results from the ATLAS trial

被引:0
|
作者
Davis, J.
Luo, M. R.
Zeidler, H.
Matsumoto, A.
Dijkmans, B. A. C.
Salvarani, C.
Veys, E.
Wong, R.
Van der Heijde, D.
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] HEOR, Abbott Labs, Abbott Pk, IL USA
[3] Med Hochshule, Hannover, Germany
[4] Ctr Rheumatol & Bone Res, Wheaton, IL USA
[5] Slotervaartziekenhuis, Amsterdam, Netherlands
[6] Div Rheumatol, Reggio Emilia, Italy
[7] UZ Ghent, Ghent, Belgium
[8] Abbott Labs, Parsippany, NJ USA
[9] Univ Hosp Maastricht, Maastricht, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:213 / 213
页数:1
相关论文
共 50 条
  • [41] Preliminary MRI results in patients with active ankylosing spondylitis treated with adalimumab for 12 weeks
    Haibel, H
    Rudwaleit, M
    Brandt, HC
    Grozdanovic, Z
    Braun, J
    Kupper, H
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S618 - S618
  • [42] Infliximab improves productivity and reduces workday loss in patients with Ankylosing Spondylitis: Results from a randomized, placebo-controlled trial
    Van der Heijde, Desiree
    Han, Chenglong
    DeVlam, Kirt
    Burmester, Gerd
    Van den Bosch, Filip
    Williamson, Paul
    Bala, Mohan
    Han, John
    Braun, Juergen
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (04): : 569 - 574
  • [43] Adalimumab reduces spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis (AS) - 52 week magnetic resonance imaging (MRI) results from the Canadian AS study
    Lambert, R. G. W.
    Salonen, D.
    Rahman, P.
    Inman, R.
    Wong, R.
    Patra, K.
    Thomson, G. T. D.
    Beaulieu, A.
    Choquette, D.
    Maksymowych, W. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 65 - 65
  • [44] Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS)
    van der Heijde, Desiree
    Dijkmans, Ben
    Schiff, Michael
    Kivitz, Alan
    de Vlam, Kurt
    Wordsworth, Paul
    Ballal, Shaila
    Kupper, Hartmut
    Wong, Robert
    Sieper, Joachim
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S579 - S580
  • [45] Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial
    Haibel, H
    Rudwaleit, M
    Brandt, HC
    Grozdanovic, Z
    Listing, J
    Kupper, H
    Braun, J
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2006, 54 (02): : 678 - 681
  • [46] Detalisation of pain in patients with ankylosing spondylitis
    Garaeva, Alina
    Shaporeva, Karina
    Abdrakipov, Rifkat
    Sukhorukova, Elena
    Gabdullina, Zulfiya
    Zamanova, Endzhe
    Lapshina, Svetlana
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (06) : 1365 - 1365
  • [47] Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
    Rudwaleit, M.
    Rodevand, E.
    Holck, P.
    Vanhoof, J.
    Kron, M.
    Kary, S.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 696 - 701
  • [48] Adalimumab in the treatment of active ankylosing spondylitis: Results of an open-label, 52-week trial
    Haibel, H
    Brandt, H
    Baraliakos, X
    Rudwaleit, M
    Listing, J
    Braun, J
    Kupper, H
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 316 - 316
  • [49] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [50] A decade of Etanercept - results of a clinical trial in patients with acitve ankylosing spondylitis
    Haibel, H.
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Braun, J.
    Sieper, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 126 - 127